ALEXIS WERNSMAN: Open Payments
NPI 1073147237 · CENTRALIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,529 in 153 payments from 42 companies in 2025. Trend: 2023 $1,190 · 2024 $1,395 · 2025 $3,529
Food & beverage: $3,169Education: $360
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $370 |
| Novartis Pharmaceuticals Corporation | 14 | $331 |
| AstraZeneca Pharmaceuticals LP | 11 | $267 |
| Incyte Corporation | 11 | $262 |
| ABBVIE INC. | 9 | $181 |
| E.R. Squibb & Sons, L.L.C. | 11 | $180 |
| Daiichi Sankyo Inc. | 6 | $147 |
| GENZYME CORPORATION | 7 | $143 |
| Exelixis Inc. | 3 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $135 |
Products named: RYBREVANT, OPDIVO, Enhertu, KISQALI, SARCLISA, MONJUVI, LIBTAYO, VENCLEXTA.
Industry payments across IL — which companies pay providers there.
